Top latest Five Precision Journal news Urban news
Hannah Mamuszka will be the Founder and CEO of Alva10, which concentrates on bringing diagnostics for the forefront of Precision Drugs by partnering with payers and employers with diagnostic developers to produce a new value-centered healthcare model that pulls diagnostics into the marketplace. Ms Mamuszka has used more than 20 years in biotech and